The second open call of L4MS targets application experiments (AE) developing new intralogistics solutions with mobile robots and the Industrial IoT platform OPIL for logistics (Open Platform for Innovations in Logistics).
The proposals should…
Clovis to acquire rights to discovery program for three additional targets for radionuclide therapy
▪ Clovis to pay approximately $12 million in upfront payments to 3B Pharmaceuticals
▪ Clovis currently planning to file an IND for…
Researchers from Charité – Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have successfully solved a longstanding problem in the diagnosis of head and neck cancers. Working alongside colleagues from Technische Universität (TU)…
ProBioGen AG, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, today announced the closing of a license agreement with Bayer AG for the GlymaxX® Technology. Under the terms of the agreement, Bayer will…
Eckert & Ziegler AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry, has been given the manufacturing authorization for additional production lines for its Ge-68/Ga-68-generators (GalliaPharm®). The…
Will Enhance Surgical Skills and Enable a Higher Quality of Care for Both Patients and Caregivers
Eckert & Ziegler AG (ISIN DE0005659700), a global radioisotope specialist headquartered in Berlin, Germany, has formed a joint venture with Chinese TCL Healthcare Equipment (Shanghai) Co., Ltd. (TCL Healthcare) for the development, production and…
Eckert & Ziegler AG (ISIN DE0005659700), a global radioisotope specialist headquartered in Berlin, Germany, has formed a joint venture with Chinese TCL Healthcare Equipment (Shanghai) Co.
The deadline for submission of proposals will be on the 28th of October 2019.
Myelo Therapeutics GmbH announced today that the European Medicines Agency (EMA) has granted an Orphan Drug Designation to its orally applied new chemical entity Myelo001 (Imidazolyl ethanamide pentandioic acid) for the treatment of Acute Radiation…
